InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+0.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Kaplan Myron, Director. Officer active across 1 company, notably CorMedix Inc.. Cumulatively, 9 reports have been published. Split: 6 buys · 0 sell. Total volume traded: €283k. History available since 17 May 2021. The latest transaction was disclosed on 17 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations9 total
25,000 shares0Common StockSEC:0001213900-25-005671:0
6,000 shares@ US$4.5439.0% of flowCommon StockSEC:0000929638-23-001538:0
Ideal exit: 12 Feb 2024 (T+270)
5,000 shares@ US$3.780.0019% mcap7.0% of flowCommon StockSEC:0001213900-22-027983:0
Ideal exit: 11 Feb 2023 (T+270)
20,000 shares0Common StockSEC:0001213900-21-067924:0
20,000 shares0Common StockSEC:0001213900-21-067924
10,000 shares@ US$5.140.0049% mcap17.6% of flowCommon StockSEC:0001213900-21-060879:0
Ideal exit: 13 Aug 2022 (T+270)
10,000 shares@ US$5.1416.0% of flowCommon StockSEC:0001213900-21-060879
Ideal exit: 13 Aug 2022 (T+270)
15,000 shares@ US$6.03180.0081% mcap28.9% of flowCommon StockSEC:0001213900-21-027991:0
Ideal exit: 11 Feb 2022 (T+270)
15,000 shares@ US$6.031828.9% of flowCommon StockSEC:0001213900-21-027991
Ideal exit: 11 Feb 2022 (T+270)
9 of 9 declarations
About Kaplan Myron
Myron Kaplan is a Board Member at CorMedix Inc. He brings valuable expertise in corporate governance and strategy. His role involves overseeing the company's operations and ensuring that shareholder interests are protected. Kaplan plays a key role in strategic decision-making and guiding the company towards its long-term goals.
